Market cap
₹8 Cr
Recently Viewed
Clear AllBSE: 541299
₹9.39
₹-0.49
(-4.96%)
As on 28-Apr-2026IST
Market cap
₹8 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
19.4
P/B Ratio
0.6
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
4.3 %
ROCE
3.6 %
Industry P/E
395.23
EV/EBITDA
9.5
Debt to Equity
0.4
Book Value
₹17
EPS
₹0.7
Face value
10
Shares outstanding
8,637,068
CFO
₹3.38 Cr
EBITDA
₹8.97 Cr
Net Profit
₹2.69 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
| -39.0 | -36.6 | -41.2 | 4.5 | -- | -12.7 | -- |
|
BSE Healthcare
| 2.6 | 5.0 | 8.0 | 6.4 | 25.0 | 13.8 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
| 23.1 | -20.2 | -22.7 | -32.5 | 198.5 | 12.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr Lalchandani Lab
|
9.4 | 8.1 | 4.5 | 0.4 | -- | 4.3 | 19.4 | 0.6 |
| 63.5 | 65.4 | 24.2 | 1.5 | 5.5 | 11 | 44.6 | 5.1 | |
| 705.3 | 36,540.5 | 4,461.2 | 397.5 | 13.4 | 9.1 | 111.7 | 7.9 | |
| 1,411.7 | 23,668.0 | 2,662.8 | 533.1 | 22.9 | 24.1 | 44.8 | 9.2 | |
| 14.1 | 14.8 | 0.6 | 0.2 | -- | 0.8 | 74.2 | 0.6 | |
| 662.3 | 26,529.2 | 3,626.9 | 315.0 | 15.0 | 13.3 | 88.2 | 11.4 | |
| 120.2 | 249.4 | 51.6 | 0.7 | 1.3 | 1.1 | 381.8 | 4.1 | |
| 127.0 | 42.6 | 16.5 | -1.4 | 6.6 | -3.6 | -- | 1.1 | |
| 17.2 | 39.1 | 0.0 | -8.7 | -- | -64.3 | -- | 3.4 | |
| 70.2 | 30.0 | 27.2 | -2.0 | -3.4 | -287.5 | -- | -28.7 |
No Review & Analysis are available.
Hospital activities
Incorporated
2011
Chairman
Arjan Lalchandani
Managing Director
Arjan Lalchandani
Headquarters
New Delhi, Delhi
Website
Looking for more details about Dr Lalchandani Labs Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsReply To The Clarification Sought By BSE
13-Apr-2026Approval Of Basis Of Allotment Under Right Issue
02-Mar-2026No News & Announcements are available.
The share price of Dr Lalchandani Labs Ltd is ₹9.39 (BSE) as of 28-Apr-2026 IST. Dr Lalchandani Labs Ltd has given a return of 4.46% in the last 1 years.
The P/E ratio of Dr Lalchandani Labs Ltd is 19.44 times as on 28-Apr-2026, a 95 discount to its peers’ median range of 395.23 times.
The P/B ratio of Dr Lalchandani Labs Ltd is 0.57 times as on 28-Apr-2026, a 83 discount to its peers’ median range of 3.40 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.61
|
0.45
|
|
2024
|
11.02
|
0.71
|
|
2023
|
0.00
|
1.38
|
|
2022
|
15.32
|
1.38
|
|
2021
|
5.96
|
0.65
|
The 52-week high and low of Dr Lalchandani Labs Ltd are Rs 21.22 and Rs 8.15 as of 28-Apr-2026.
Dr Lalchandani Labs Ltd has a market capitalisation of ₹ 8 Cr as on 28-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dr Lalchandani Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.